Amelioration of Oxidative Stress and Neuroinflammation in Lipopolysaccharide-induced Memory Impairment Using Rosmarinic Acid in Mice
Overview
Neurology
Affiliations
Oxidative stress plays a pivotal part in the manifestation of neuroinflammation, which further leads to neurodegenerative diseases like Alzheimer's disease (AD). Systemic administration of lipopolysaccharide (LPS) induces neuroinflammation resulting in memory impairment (MI) and cognitive decline. In this study, we evaluated whether prophylactic administration of Rosmarinic acid (RA), a naturally occurring compound, exerts a neuroprotective effect in LPS-induced MI and cognitive decline. Herein, Swiss albino mice were pre-treated with RA (0.5 mg/kg and 1 mg/kg i.p.) for 28 days and were intermittently exposed to LPS (0.25 mg/kg i.p.) for 7 days. LPS caused poor memory retention and increased cognitive decline in Morris water maze (MWM) and Y maze paradigms respectively. Additionally, LPS increased oxidative stress which was denoted by a decrease in superoxide dismutase (SOD) activity, decrease in reduced glutathione (GSH) levels, and increased lipid peroxidation in the brain. Imbalance in the cholinergic system was analyzed by measuring the acetylcholinesterase (AChE) activity. Pre-treatment with RA improved memory and behavioral disturbances by alleviating oxidative stress and AChE activity. LPS augmented levels of tumor necrosis factor (TNF-α), interleukin (IL)-6, caspase-3, and c-Jun. Pre-treatment with RA revitalized the elevated levels of proinflammatory cytokines and apoptotic proteins. In conclusion, this study showcases the amelioration of MI by RA in LPS-challenged memory and cognitive decline, which could be credited to its anti-oxidant effect, inhibitory effect on both proinflammatory cytokines and apoptotic regulators, and reduction in AChE activity.
Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.
Flieger J, Forma A, Flieger W, Flieger M, Gawlik P, Dzierzynski E Int J Mol Sci. 2024; 25(16).
PMID: 39201668 PMC: 11354426. DOI: 10.3390/ijms25168982.
Ali W, Choe K, Park J, Ahmad R, Park H, Kang M Front Pharmacol. 2024; 15:1443552.
PMID: 39185307 PMC: 11341365. DOI: 10.3389/fphar.2024.1443552.
Bastawy E, Eraslan I, Voglsanger L, Suphioglu C, Walker A, Dean O Int J Mol Sci. 2024; 25(13).
PMID: 39000495 PMC: 11242700. DOI: 10.3390/ijms25137391.
Chen Y, Xu R, Liu Q, Zeng Y, Chen W, Liu Y Mol Neurobiol. 2024; 61(12):10138-10158.
PMID: 38703342 DOI: 10.1007/s12035-024-04206-4.
Liang Y, Kang X, Zhang H, Xu H, Wu X J Neuroinflammation. 2023; 20(1):271.
PMID: 37990234 PMC: 10662506. DOI: 10.1186/s12974-023-02958-9.